INNOVA CAPTAB
Back to Cashflow Statement
|
INNOVA CAPTAB Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹92 Cr | ₹361 Cr | ₹27 Cr | ₹125 Cr | ₹-19 Cr |
What is the latest Cash Flow from Financing Activities ratio of INNOVA CAPTAB ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹92 Cr |
| Mar2024 | ₹361 Cr |
| Mar2023 | ₹27 Cr |
| Mar2022 | ₹125 Cr |
| Mar2021 | ₹-19 Cr |
How is Cash Flow from Financing Activities of INNOVA CAPTAB Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹92 Cr | -74.63 | |
| Mar2024 | ₹361 Cr | 1,231.88 | |
| Mar2023 | ₹27 Cr | -78.25 | |
| Mar2022 | ₹125 Cr | Positive | |
| Mar2021 | ₹-19 Cr | - | |
Compare Cash Flow from Financing Activities of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹3,804.4 Cr | -6.8% | -2% | -19.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,407.0 Cr | -2.2% | 2.5% | 1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,596.0 Cr | -1.2% | -4.5% | 5.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,619.0 Cr | -2.1% | -0.2% | 36.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,544.0 Cr | -2.4% | -2.1% | 11.5% | Stock Analytics | |
| CIPLA | ₹98,767.6 Cr | -4.6% | -8% | -16.8% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | -6.8% |
-2% |
-19.5% |
| SENSEX | -3.7% |
-13.2% |
-2% |
You may also like the below Video Courses